| 1350653-20-1 Basic information More.. |
Product Name: | vericiguat | Synonyms: | vericiguat;BAY1021189;Carbamic acid, N-[4,6-diamino-2-[5-fluoro-1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-, methyl ester;Vericiguat (BAY 1021189);MK-1242;methyl (4,6-diamino-2-(5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)carbamate (Vericiguat);Methyl (4,6-diamino-2-(5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)carbamate;Inhibitor,BAY-1021189,BAY 1021189,inhibit,Guanylate Cyclase,Vericiguat | CAS: | 1350653-20-1 | MF: | C19H16F2N8O2 | MW: | 426.38 | EINECS: | | Mol File: | 1350653-20-1.mol | ![1350653-20-1](/CAS/20200611/GIF/1350653-20-1.gif) |
Use
Vericiguat is a novel oral soluble guanylate cyclase (sGC) stimulator that enhances the cyclic guanosine monophosphate (GMP) production pathway, by directly stimulating soluble guanylate cyclase activity, as well as sensitizing soluble guanylate cyclase to endogenous NO. It was initially developed for potential to reduce mortality and morbidity associated with chronic heart failure with reduced ejection fraction.
- Vericiguat
-
- US $0.00-0.00 / g
- 2024-05-28
- CAS:1350653-20-1
- Min. Order: 1g
- Purity: 98%
- Supply Ability: 10kg/month
- Vericiguat
-
- US $0.00 / g
- 2024-03-12
- CAS:1350653-20-1
- Min. Order: 1g
- Purity: 98% HPLC
- Supply Ability: 100kg
- Vericiguat
-
- US $0.00-0.00 / KG
- 2023-11-01
- CAS:1350653-20-1
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 200
|
1350653-20-1
Recommend Suppliers |
|